Defining high risk prostate cancer : Where do we set the bar? A translational science approach to risk stratificationTHOMPSON, Ian M.The Journal of urology. 2006, Vol 176, Num 6, issn 0022-5347, S21-S24, 2Article

Prostate-specific antigen: A review of the validation of the most commonly used cancer biomarkerHERNANDEZ, Javier; THOMPSON, Ian M.Cancer. 2004, Vol 101, Num 5, pp 894-904, issn 0008-543X, 11 p.Article

Adjuvant radiotherapy for high-risk patients following radical prostatectomySWANSON, Gregory P; THOMPSON, Ian M.Urologic oncology. 2007, Vol 25, Num 6, pp 515-519, issn 1078-1439, 5 p.Conference Paper

Impact of diabetes mellitus on the presentation and outcomes of Fournier's gangreneNISBET, Alan A; THOMPSON, Ian M.Urology (Ridgewood, NJ). 2002, Vol 60, Num 5, pp 775-779, issn 0090-4295, 5 p.Article

Familial risk and familial survival in prostate cancerHEMMINKI, Kari.World journal of urology (Print). 2012, Vol 30, Num 2, pp 143-148, issn 0724-4983, 6 p.Article

Prostate cancer screening and disease management : How screening may have an unintended effect on survival and mortality-the camel's nose effectWALSH, Rhonda M; THOMPSON, Ian M.The Journal of urology. 2007, Vol 177, Num 4, pp 1303-1306, issn 0022-5347, 4 p.Article

The Prostate Cancer Prevention Trial: design, status, and promise : Can we really the risk for prostate cancer?THOMPSON, Ian M; TANGEN, Catherine; GOODMAN, Phyllis et al.World journal of urology (Print). 2003, Vol 21, Num 1, pp 28-30, issn 0724-4983, 3 p.Article

Epidemiology, detection, and prevention of prostate cancerANKERST, Donna P; THOMPSON, Ian M.World journal of urology (Print). 2012, Vol 30, Num 2, issn 0724-4983, 148 p.Serial Issue

United States military contributions to the National Cancer Institute : Innovations in Urology From Military MedicineSARVIS, Jamey A; THOMPSON, Ian M.Urologic oncology. 2009, Vol 27, Num 5, pp 558-561, issn 1078-1439, 4 p.Article

Treatment options in lymph node-positive prostate cancerSWANSON, Gregory P; THOMPSON, Ian M; BASLER, Joseph et al.Cancer. 2006, Vol 106, Num 12, pp 2531-2539, issn 0008-543X, 9 p.Article

Post-prostatectomy bleeding managed by endovascular embolizationIBARRA, Rodolfo; MAGEE, Chris; FERRAL, Hector et al.The Journal of urology. 2003, Vol 169, Num 1, pp 276-277, issn 0022-5347, 2 p.Article

Limited PSA Testing in Indigent Men in South Texas: An Appropriate Care or Missing a Prevention Opportunity?YUANYUAN LIANG; FEI DU; THOMPSON, Ian M et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 9, pp 1489-1496, issn 1055-9965, 8 p.Article

Potential for prostate cancer prevention through physical activityYOUNG-MCCAUGHAN, Stacey.World journal of urology (Print). 2012, Vol 30, Num 2, pp 167-179, issn 0724-4983, 13 p.Article

Genitourinary EmergenciesHEMPHILL, Robin R; MANTHEY, David E; THOMPSON, Ian M et al.Emergency medicine clinics of North America. 2001, Vol 19, Num 3, issn 0733-8627, 319 p.Serial Issue

Disappearance of well-differentiated carcinoma of the prostate : Effect of transurethral resection of the prostate, prostate-specific antigen, and prostate biopsyENDRIZZI, Joseph; OPTENBERG, Scott; BYERS, Ruth et al.Urology (Ridgewood, NJ). 2001, Vol 57, Num 4, pp 733-736, issn 0090-4295Conference Paper

Diet and prostate cancer preventionMARSHALL, James R.World journal of urology (Print). 2012, Vol 30, Num 2, pp 157-165, issn 0724-4983, 9 p.Article

Serendipitous renal cell carcinoma in the post-CT era: continued evidence in improved outcomesLESLIE, Jeffrey A; PRIHODA, Tom; THOMPSON, Ian M et al.Urologic oncology. 2003, Vol 21, Num 1, pp 39-44, issn 1078-1439, 6 p.Article

Ventral bladder hernia following tubal ligationPENA, Alberto A; BERMEJO, Carlos E; THOMPSON, Ian M et al.The Journal of urology. 2002, Vol 168, Num 4, issn 0022-5347, p. 1502, 1Article

Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialFIGG, William D; CHAU, Cindy H; VAN BOKHOVEN, Adrie et al.Urology (Ridgewood, NJ). 2014, Vol 84, Num 1, pp 127-131, issn 0090-4295, 5 p.Article

Plasma Vitamin D and Prostate Cancer Risk: Results from the Selenium and Vitamin E Cancer Prevention TrialKRISTAL, Alan R; TILL, Cathee; MINASIAN, Lori M et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 8, pp 1494-1504, issn 1055-9965, 11 p.Article

Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO GuidelineTHOMPSON, Ian M; VALICENTI, Richard K; WOLF, J. Stuart et al.The Journal of urology. 2013, Vol 190, Num 2, pp 441-449, issn 0022-5347, 9 p.Article

Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance StudyLIN, Daniel W; NEWCOMB, Lisa F; WEI, John T et al.Clinical cancer research (Print). 2013, Vol 19, Num 9, pp 2442-2450, issn 1078-0432, 9 p.Article

Finasteride Reduces the Risk of Incident Clinical Benign Prostatic HyperplasiaKELLOGG PARSONS, J; SCHENK, Jeannette M; ARNOLD, Kathryn B et al.European urology. 2012, Vol 62, Num 2, pp 234-241, issn 0302-2838, 8 p.Article

Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrastsROVE, Kyle O; CRAWFORD, E. David.World journal of urology (Print). 2012, Vol 30, Num 2, pp 137-142, issn 0724-4983, 6 p.Article

Prospective blinded comparison of real-time sonoelastography targeted versus randomised biopsy of the prostate in the primary and re-biopsy settingGANZER, Roman; BRANDTNER, Andreas; WIELAND, Wolf F et al.World journal of urology (Print). 2012, Vol 30, Num 2, pp 219-223, issn 0724-4983, 5 p.Article